SAINT PAUL, MINNESOTA – The Prescription Drug Price Transparency Act (SF 1098), a bill to address skyrocketing prescription drug pricing, advanced out of the House Ways and Means Committee today on a 23-1 vote. Rep. Kelly Morrison (DFL-Deephaven), a practicing physician, is the chief author of the bipartisan legislation.
“All Minnesotans deserve access to the prescription medication that they need to survive and thrive,” said Rep. Morrison. “Prescription drugs don’t work if people can’t afford them. Creating more transparency about why drugs are priced the way they are is an important first step in raising awareness about the role of drug prices in the cost of health care, and in helping drive down those prices.” Continue reading “Bipartisan ‘Prescription Drug Price Transparency Act’ Advances in the House”